Copenhagen Head Injury Ciclosporin (CHIC) Study: An open-label, uncontrolled Phase II-study to investigate pharmacokinetics, safety and biomarkers of effectiveness of NeuroSTAT® (ciclosporin) in patients with severe Traumatic Brain Injury (TBI).

Registry ID

EUCTR2012-000756-34

Source registry

EUCTR

Status

Prematurely Ended

Phase

PHASE2

Sponsor

NeuroVive Pharmaceutical AB

Start date

2012-09-20

Last update

2026-08-16

Conditions

• Severe Traumatic Brain Injury

Summary

To establish safety and to characterise the pharmacokinetic profile of two dosing regimens of ciclosporin in severe Traumatic Brain Injury (TBI) patients.

Locations

• , , Denmark

Related clinical trials

• Vagus Nerve Stimulation in Patients in Comatose State
• Feasibility and Safety of Targeting Neutral vs Liberal Fluid Balance in Traumatic Brain Injured Patients- LIMIT-TBI Trial
• SeeMe: Using Automated Facial Tracking to Detect Voluntary Behavior in Brain Injury
• External Lumbar Drainage to Reduce ICP in Severe TBI: a Phase 1 Clinical Trial
• Benchmark Evidence Led by Latin America: Trial of Intracranial Pressure - Pediatrics
• Incidence, Characteristics and Evolution of Cerebral Vasospasm With Clinical Impact in Moderate to Severe Traumatic Brain Injury Complicated by Subarachnoid Hemorrhage at Martinique University Hospital

View on source registry